US 8697874
Heterocyclic compound and use thereof
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8697874 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P43/00